Lyotropic Therapeutics, Inc.
Records under this name other than the patents Lyotropic Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Lyotropic Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,858,927 | Method for Protection of Peptides or Proteins Against Non-Enzymatic Deamidation Lapsed on the fee record Ended Oct 14, 2026 · High confidence | Lapsed on the fee record | Ended Oct 14, 2026 | High confidence |
| US 8,728,829 | Compositions for binding to assay substrata and methods of using Lapsed on the fee record Ended May 20, 2026 · USPTO record | Lapsed on the fee record | Ended May 20, 2026 | USPTO record |
| US 7,758,890 | Treatment Using Dantrolene Formerly held Term ended Term ended Jun 30, 2025 · Medium confidence | Term ended | Term ended Jun 30, 2025 | Medium confidence |
| US 8,449,863 | Stabilized uncoated particles of reversed liquid crystalline phase materials Lapsed on the fee record Ended May 28, 2025 · USPTO record | Lapsed on the fee record | Ended May 28, 2025 | USPTO record |
| US 7,968,124 | Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use Term ended Term ended Jul 27, 2024 · USPTO record | Term ended | Term ended Jul 27, 2024 | USPTO record |
| US 9,394,339 | Stabilized Formulations of Peptides and Proteins Protecting Against Non-Enzymatic Degradation Lapsed on the fee record Ended Jul 19, 2024 · High confidence | Lapsed on the fee record | Ended Jul 19, 2024 | High confidence |
| US 8,128,905 | Stabilized uncoated particles of reversed liquid crystalline phase materials Lapsed on the fee record Ended Mar 6, 2024 · USPTO record | Lapsed on the fee record | Ended Mar 6, 2024 | USPTO record |
| US 8,128,906 | Stabilized uncoated particles of reversed liquid crystalline phase materials Lapsed on the fee record Ended Mar 6, 2024 · USPTO record | Lapsed on the fee record | Ended Mar 6, 2024 | USPTO record |
| US 6,991,809 | Particles with improved solubilization capacity Term ended Term ended Jul 19, 2023 · USPTO record | Term ended | Term ended Jul 19, 2023 | USPTO record |
| US 8,685,460 | Treatment Using Dantrolene Term ended Term ended Feb 15, 2023 · Medium confidence | Term ended | Term ended Feb 15, 2023 | Medium confidence |